Beyond benzodiazepines: a meta-analysis and narrative synthesis of the efficacy and safety of alternative options for alcohol withdrawal syndrome management Dimy FluyauVasanth Kattalai KailasamChristopher G. Pierre Review 28 June 2023 Pages: 1147 - 1157
Proton pump inhibitor use: systematic review of global trends and practices Lelwala Guruge Thushani ShanikaAndrew ReynoldsRhiannon Braund Review Open access 07 July 2023 Pages: 1159 - 1172
Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration Massimo MapelliIrene MattavelliPiergiuseppe Agostoni Research Open access 27 June 2023 Pages: 1173 - 1184
Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study Katja S. JustKaren A. SchultzeJulia C. Stingl Research Open access 29 June 2023 Pages: 1185 - 1193
A new model (Alfalfa-Warfarin-GIB) for predicting the risk of major gastrointestinal bleeding in warfarin patients Shuyi WuMeina LvJinhua Zhang Research 01 July 2023 Pages: 1195 - 1204
The effect of perioperative diuretic administration on acute kidney injury in patients with acute myocardial infarction after percutaneous coronary intervention: a real-world retrospective study Yuxin NongXuebiao WeiDanqing Yu Research 01 July 2023 Pages: 1205 - 1213
Improved correction formulas to estimate iohexol clearance from simple models Qian DongUwe FuhrMax Taubert Research Open access 08 July 2023 Pages: 1215 - 1217
A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease Christina Lourdes MayerKathleen KoeckPatrick Yue Research Open access 12 July 2023 Pages: 1219 - 1228
Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study) Geoffrey StrobbeLouise GaboriauGuillaume Marliot Research 13 July 2023 Pages: 1229 - 1238
Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022) Jialing LinSallie-Anne PearsonJuliana de Oliveira Costa Research Open access 14 July 2023 Pages: 1239 - 1248
The contribution of genotype-guided selection of P2Y12 inhibitor on prognosis in ACS /CCS patients undergoing percutaneous coronary intervention: a retrospective cohort study Yan WuDongbiao YuTianlu Shi Research 14 July 2023 Pages: 1249 - 1259
Medicines postpartum in Sweden and coverage in Janusmed Breastfeeding A. B. AsplundP. Dreher SköldM. L. Andersson Research Open access 15 July 2023 Pages: 1261 - 1269
Therapeutic drug monitoring of voriconazole and CYP2C19 phenotype for dose optimization in paediatric patients Lin HuQi HuangZeying Feng Research 17 July 2023 Pages: 1271 - 1278
Might chronic spontaneous urticaria develop after SARS-CoV-2 vaccinations? Öner Özdemir Correspondence 01 July 2023 Pages: 1279 - 1280